Resolvin D1 protects against sepsis‐induced cardiac injury in mice

Triggering the Resolution of Immune Mediated Inflammatory Diseases: Can Targeting Leukocyte Migration Be the Answer?

(2019) Sophie J. Hopkin et al.   Frontiers in Pharmacology

A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis

(2019) Yong-Hyun Han et al.   JOURNAL OF CLINICAL INVESTIGATION

Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways

(2019) Habib Yaribeygi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Protective Role of Hepcidin in Polymicrobial Sepsis and Acute Kidney Injury

(2019) Yogesh Scindia et al.   Frontiers in Pharmacology

Treatment with 3,4-dihydroxyphenylethyl alcohol glycoside ameliorates sepsis-induced ALI in mice by reducing inflammation and regulating M1 polarization

(2019) Yuzhen Zhuo et al.   BIOMEDICINE & PHARMACOTHERAPY

Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

(2019) Pei Shang et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages

(2019) Hua-Wei Zhang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF‐kB/NLRP3 pathway

(2019) Man Luo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Resolution of inflammation during multiple sclerosis

(2019) F. Ruiz et al.   Seminars in Immunopathology

Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs

(2019) Victor Fattori et al.   PHARMACOLOGICAL RESEARCH

Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury

(2018) Yuzhen Zhuo et al.   INFLAMMATION

Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

(2018) Charles N. Serhan et al.   JOURNAL OF CLINICAL INVESTIGATION

Towards targeting resolution pathways of airway inflammation in asthma

(2018) Cindy Barnig et al.   PHARMACOLOGY & THERAPEUTICS

Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution

(2018) Giovanni Musso et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation

(2018) Paul C. Norris et al.   Scientific Reports

Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments

(2017) Yan-Cun Liu et al.   Frontiers in Immunology

Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis

(2017) Donald B. Hoover et al.   Frontiers in Immunology

Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis

(2016) Ping Fu et al.   CHINESE MEDICAL JOURNAL

The immune system's role in sepsis progression, resolution, and long-term outcome

(2016) Matthew J. Delano et al.   IMMUNOLOGICAL REVIEWS

The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma

(2016) Érika Pereira Zambalde et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32

(2016) Mattia Schmid et al.   JOURNAL OF IMMUNOLOGY

Maresin 1 Mitigates Inflammatory Response and Protects Mice from Sepsis

(2016) Ruidong Li et al.   MEDIATORS OF INFLAMMATION

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function

(2015) Vasundhara Kain et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Resolvin D1 Stimulates Alveolar Fluid Clearance through Alveolar Epithelial Sodium Channel, Na,K-ATPase via ALX/cAMP/PI3K Pathway in Lipopolysaccharide-Induced Acute Lung Injury

(2014) Q. Wang et al.   JOURNAL OF IMMUNOLOGY

Ginsenoside Rb3 Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of JNK-Mediated NF-κB Pathway: A Mouse Cardiomyocyte Model

(2014) Lijia Ma et al.   PLoS One

Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury

(2014) Jiao Chen et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis

(2013) Ha-Na Lee et al.   BIOCHEMICAL PHARMACOLOGY

The role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsis

(2013) Xiaoping Li et al.   BMC Cardiovascular Disorders

Resolvin D1, an Endogenous Lipid Mediator for Inactivation of Inflammation-Related Signaling Pathways in Microglial Cells, Prevents Lipopolysaccharide-Induced Inflammatory Responses

(2013) Min-Xuan Xu et al.   CNS Neuroscience & Therapeutics

Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways

(2012) Bruce D. Levy   Frontiers in Immunology

Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-  expression and improves cardiac function during endotoxemia

(2011) T. Zhang et al.   CARDIOVASCULAR RESEARCH

Luteolin Prevents LPS-Induced TNF-α Expression in Cardiac Myocytes Through Inhibiting NF-κB Signaling Pathway

(2010) Lihua Lv et al.   INFLAMMATION

Actual incidence of global left ventricular hypokinesia in adult septic shock

(2008) Antoine Vieillard-Baron et al.   CRITICAL CARE MEDICINE

Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders

(2008) Per Anderson et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE